SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007823
Filing Date
2019-08-09
Accepted
2019-08-09 08:48:04
Documents
73
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20190630x10q.htm   iXBRL 10-Q 2637261
2 EX-10.2 vygr-20190630ex1029c79f8.htm EX-10.2 116993
3 EX-10.3 vygr-20190630ex103fc3820.htm EX-10.3 143406
4 EX-10.4 vygr-20190630ex104c1d867.htm EX-10.4 325701
5 EX-10.5 vygr-20190630ex10518a405.htm EX-10.5 15165
6 EX-10.6 vygr-20190630ex106f8be74.htm EX-10.6 52793
7 EX-31.1 vygr-20190630ex311297d04.htm EX-31.1 16687
8 EX-31.2 vygr-20190630ex312c50db4.htm EX-31.2 16721
9 EX-32.1 vygr-20190630ex32132ae57.htm EX-32.1 15356
10 GRAPHIC vygr-20190630x10q006.jpg GRAPHIC 73006
  Complete submission text file 0001558370-19-007823.txt   10747477

Data Files

Seq Description Document Type Size
11 EX-101.SCH vygr-20190630.xsd EX-101.SCH 75612
12 EX-101.CAL vygr-20190630_cal.xml EX-101.CAL 62785
13 EX-101.DEF vygr-20190630_def.xml EX-101.DEF 326925
14 EX-101.LAB vygr-20190630_lab.xml EX-101.LAB 584100
15 EX-101.PRE vygr-20190630_pre.xml EX-101.PRE 482354
16 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20190630x10q_htm.xml XML 1737814
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 191011430
SIC: 2836 Biological Products, (No Diagnostic Substances)